These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35163733)

  • 1. Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson's Patient-Derived Neuronal Cells.
    Seebauer L; Schneider Y; Drobny A; Plötz S; Koudelka T; Tholey A; Prots I; Winner B; Zunke F; Winkler J; Xiang W
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation.
    Pieger K; Schmitt V; Gauer C; Gießl N; Prots I; Winner B; Winkler J; Brandstätter JH; Xiang W
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Synuclein oligomers impair neuronal microtubule-kinesin interplay.
    Prots I; Veber V; Brey S; Campioni S; Buder K; Riek R; Böhm KJ; Winner B
    J Biol Chem; 2013 Jul; 288(30):21742-54. PubMed ID: 23744071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines.
    Sigutova V; Xiang W; Regensburger M; Winner B; Prots I
    Brain Behav Immun; 2024 Nov; 122():216-230. PubMed ID: 39128571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.
    Stykel MG; Humphries K; Kirby MP; Czaniecki C; Wang T; Ryan T; Bamm V; Ryan SD
    FASEB J; 2018 Oct; 32(10):5350-5364. PubMed ID: 29688812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young human alpha synuclein transgenic (BAC-SNCA) mice display sex- and gene-dose-dependent phenotypic disturbances.
    Moceri S; Bäuerle N; Habermeyer J; Ratz-Wirsching V; Harrer J; Distler J; Schulze-Krebs A; Timotius IK; Bluhm A; Hartlage-Rübsamen M; Roßner S; Winkler J; Xiang W; Hörsten SV
    Behav Brain Res; 2024 Mar; 460():114781. PubMed ID: 38043677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular milieu of Parkinson's disease patient brain cells modulates alpha-synuclein protein aggregation.
    Gustavsson N; Savchenko E; Klementieva O; Roybon L
    Acta Neuropathol Commun; 2021 Sep; 9(1):153. PubMed ID: 34530929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
    Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
    Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease.
    Cole TA; Zhao H; Collier TJ; Sandoval I; Sortwell CE; Steece-Collier K; Daley BF; Booms A; Lipton J; Welch M; Berman M; Jandreski L; Graham D; Weihofen A; Celano S; Schulz E; Cole-Strauss A; Luna E; Quach D; Mohan A; Bennett CF; Swayze EE; Kordasiewicz HB; Luk KC; Paumier KL
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease.
    Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG
    J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
    Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
    Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
    Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
    Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nurr1 repression mediates cardinal features of Parkinson's disease in α-synuclein transgenic mice.
    Argyrofthalmidou M; Spathis AD; Maniati M; Poula A; Katsianou MA; Sotiriou E; Manousaki M; Perier C; Papapanagiotou I; Papadopoulou-Daifoti Z; Pitychoutis PM; Alexakos P; Vila M; Stefanis L; Vassilatis DK
    Hum Mol Genet; 2021 Jul; 30(16):1469-1483. PubMed ID: 33902111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducible Alpha-Synuclein Expression Affects Human Neural Stem Cells' Behavior.
    Zasso J; Ahmed M; Cutarelli A; Conti L
    Stem Cells Dev; 2018 Jul; 27(14):985-994. PubMed ID: 29669468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.